With the suspension of the registration of 36 similar bio-therapeutic products in Sri Lanka, the country's healthcare market has become an open ground for the monopoly... Read more
Waters India, a fully owned subsidiary of Waters in the US, is celebrating its silver jubilee anniversary in India. Driven by a long-term commitment to the region,... Read more
Over the past decade, the world has invested enormous resources and energy into the development of new and life-saving vaccines. Current vaccination programs save... Read more
Respiratory syncytial virus (RSV), a disease that causes infections of the lower respiratory tract mostly in infants and children, claims lives of nearly 200,000... Read more
Bangalore: British pharmaceutical giant GlaxoSmithKline (GSK), which was facing civil and criminal liabilities in the US for unlawful promotion of certain prescription... Read more
Indian pharmaceutical companies continue to receive approval from the Foreign Investment Promotion Board (FIPB), a national agency of Government of India that provides... Read more
Biotechnology has helped Jiangxi Copper, China's largest producer of copper, remove tons of copper from waste water at its plant in Dexing City of Jiangxi Province.... Read more
The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making... Read more
In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An independent M&A intelligence service mergermarket... Read more
China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with... Read more
In 2011, the global pharmaceutical industry saw 504 mergers and acquisitions (M&A), with a total transaction value of $90 billion. Furthermore, the number of transactions... Read more
About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges in Asia Pacific (APAC)... Read more
The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent of the $120 billion pharmaceutical... Read more
The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devices market. Currently, the medical devices... Read more
A rapidly aging population has burdened the healthcare system both in terms of funding and facilities and is of great concern for the Japanese government. To ease... Read more
Survey Box